Number of the records: 1  

Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane

  1. TitleModulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane
    Author Hunáková Ľuba 1967- SAVEXONK - Ústav experimentálnej onkológie SAV    ORCID
    Co-authors Gronesová Paulína 1982- SAVEXONK - Ústav experimentálnej onkológie SAV

    Horváthová Eva 1969- SAVEXONK - Ústav experimentálnej onkológie SAV    SCOPUS    RID    ORCID

    Chalupa Ivan 1946- SAVEXONK - Ústav experimentálnej onkológie SAV

    Cholujová Dana 1975- SAVEXONK - Ústav experimentálnej onkológie SAV

    Duraj Jozef 1949- SAVEXONK - Ústav experimentálnej onkológie SAV

    Sedlák Ján 1957- SAVEXONK - Ústav experimentálnej onkológie SAV

    Source document Toxicology Letters : official journal of EUROTOX. Vol. 230, no. 3 (2014), p. 479-486
    Languageeng - English
    CountryNL - Netherlands
    Document kindrozpis článkov z periodík (rbx)
    CitationsTURRINI, Eleonora - FERRUZZI, Lorenzo - FIMOGNARI, Carmela. Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues. In EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. ISSN 1742-5255, 2014, vol. 10, no. 12, pp. 1677.
    LEE, Yu-Chieh - LEE, Chii-Hong - TSAI, Hsiang-Ping - AN, Herng-Wei - LEE, Chi-Ming - WU, Jen-Chine - CHEN, Chien-Shu - HUANG, Shih-Hao - HWANG, Jaulang - CHENG, Kur-Ta - LEIW, Phui-Ly - CHEN, Chi-Long - LIN, Chun-Mao. Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer. In PLOS ONE. ISSN 1932-6203, 2015, vol. 10, no. 7, pp.
    LAN, FengMing - PAN, Qiang - YU, Huiming - YUE, Xiao. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/-catenin signaling in glioblastoma. In JOURNAL OF NEUROCHEMISTRY. ISSN 0022-3042, 2015, vol. 134, no. 5, pp. 811.
    LIANG, Hao - LI, Ruimin - YUAN, Qipeng. Recent progress in the study of natural active isothiocyanates. In Beijing Huagong Daxue Xuebao (Ziran Kexueban)/Journal of Beijing University of Chemical Technology (Natural Science Edition). ISSN 16714628, 2015-01-01, 42, 2, pp. 1-12.
    GRAY, Steven G. Epigenetics of Cisplatin Resistance. In Epigenetic Cancer Therapy, 2015-07-22, pp. 613-637.
    RACKAUSKAS, Rokas - ZHOU, Dachen - USELIS, Simonas - STRUPAS, Kestutis - HERR, Ingrid - SCHEMMER, Peter. Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins. In ONCOLOGY REPORTS. ISSN 1021-335X, 2017, vol. 37, no. 6, pp. 3660-3666.
    HOU, Zhanjun - GATTOC, Leda - O'CONNOR, Carrie - YANG, Si - WALLACE-POVIRK, Adrianne - GEORGE, Christina - ORR, Steve - POLIN, Lisa - WHITE, Kathryn - KUSHNER, Juiwanna - MORRIS, Robert T. - GANGJEE, Aleem - MATHERLY, Larry H. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor alpha and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d] pyrimidine Antifolates. In MOLECULAR CANCER THERAPEUTICS. ISSN 1535-7163, 2017, vol. 16, no. 5, pp. 819-830.
    MILCZAREK, Malgorzata - MIELCZAREK, Lidia - LUBELSKA, Katarzyna - DABROWSKA, Aleksandra - CHILMONCZYK, Zdzislaw - MATOSIUK, Dariusz - WIKTORSKA, Katarzyna. In Vitro Evaluation of Sulforaphane and a Natural Analog as Potent Inducers of 5-Fluorouracil Anticancer Activity. In MOLECULES. ISSN 1420-3049, 2018, vol. 23, no. 11, pp.
    KIM, Jong-Eun - LEE, Ki Won. Molecular Targets of Phytochemicals for Skin Inflammation. In CURRENT PHARMACEUTICAL DESIGN. ISSN 1381-6128, 2018, vol. 24, no. 14, pp. 1533-1550.
    BRIONES-HERRERA, Alfredo - EUGENIO-PEREZ, Dianelena - GABRIELA REYES-OCAMPO, Jazmin - RIVERA-MANCIA, Susana - PEDRAZA-CHAVERRI, Jose. New highlights on the health-improving effects of sulforaphane. In FOOD & FUNCTION. ISSN 2042-6496, 2018, vol. 9, no. 5, pp. 2589-2606.
    ROGALSKA, Aneta - BUKOWSKA, Barbara - MARCZAK, Agnieszka. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. In TOXICOLOGY IN VITRO. ISSN 0887-2333, 2018, vol. 47, no., pp. 48-62.
    BAEK, Jiwon - LEE, Dahae - LEE, Tae Kyoung - SONG, Ji Hoon - LEE, Ju Sung - LEE, Seong - YOO, Sang-Woo - KANG, Ki Sung - MOON, Eunjung - LEE, Sanghyun - KIM, Ki Hyun. (-)-9'-O-(alpha-L-Rhamnopyranosyl) lyoniresinol from Lespedeza cuneata suppresses ovarian cancer cell proliferation through induction of apoptosis. In BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. ISSN 0960-894X, 2018, vol. 28, no. 2, pp. 122-128.
    SHI, Xiaoming - ZHAO, Wei - YANG, Yongbin - WU, Shengchun - LV, Bonan. Salidroside could enhance the cytotoxic effect of L-OHP on colorectal cancer cells. In MOLECULAR MEDICINE REPORTS. ISSN 1791-2997, 2018, vol. 17, no. 1, pp. 51-58.
    CHEN, Luo - CHAN, Lai Sheung - LUNG, Hong Lok - YIP, Timothy Tak Chun - NGAN, Roger Kai Cheong - WONG, Jonathan Woon Chung - LO, Kwok Wai - NG, Wai Tong - LEE, Anne Wing Mui - TSAO, George Sai Wah - LUNG, Maria Li - MAK, Nai Ki. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis. In PHYTOMEDICINE. ISSN 0944-7113, 2019, vol. 63, no., pp.
    NEGRETTE-GUZMAN, Mario. Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy. In EUROPEAN JOURNAL OF PHARMACOLOGY. ISSN 0014-2999, 2019, vol. 859, no., pp.
    TIAN, Miao - TIAN, Dan - QIAO, Xiaofang - LI, Jinlong - ZHANG, Leilei. Modulation of Myb-induced NF-kB-STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, 2019, vol. 234, no. 11, pp. 21126-21134.
    GONG, T.T. - LIU, X.D. - ZHAN, Z.P. - WU, Q.J. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells. In EXPERIMENTAL CELL RESEARCH. ISSN 0014-4827, AUG 15 2020, vol. 393, no. 2.
    CALCABRINI, C. - MAFFEI, F. - TURRINI, E. - FIMOGNARI, C. Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects. In FRONTIERS IN PHARMACOLOGY. ISSN 1663-9812, MAY 1 2020, vol. 11.
    HARRIS, C.M. - ZAMPERONI, K.E. - SERNOSKIE, S.C. - CHOW, N.S.M. - MASSEY, T.E. Effects of in vivo treatment of mice with sulforaphane on repair of DNA pyridyloxylbutylation. In TOXICOLOGY. ISSN 0300-483X, APR 30 2021, vol. 454. Dostupné na: https://doi.org/10.1016/j.tox.2021.152753.
    WANG, Q. - BAO, Y.P. Nanodelivery of natural isothiocyanates as a cancer therapeutic. In FREE RADICAL BIOLOGY AND MEDICINE. ISSN 0891-5849, MAY 1 2021, vol. 167, p. 125-140. Dostupné na: https://doi.org/10.1016/j.freeradbiomed.2021.02.044.
    TOSSETTA, G. - MARZIONI, D. Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway. In PHARMACOLOGICAL RESEARCH. ISSN 1043-6618, SEP 2022, vol. 183. Dostupné na: https://doi.org/10.1016/j.phrs.2022.106365.
    TAYEBI-KHORAMI, M. - CHEGENI, N. - TAHMASBI-BIRGANI, M. - DANYAEI, A. - FARDID, R. - ZAFARI, J. Enhancement of Cisplatin Sensitivity by Microwave Radiation in Ovarian Cancer Cells. In PHARMACEUTICAL SCIENCES. ISSN 1735-403X, APR 2022, vol. 28, no. 2, p. 295-303. Dostupné na: https://doi.org/10.34172/PS.2021.51.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2014
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1016/j.toxlet.2014.08.018
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201420133.355Q11.106Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.